rcs research tirzepatide Dual Agonist (GLP-1/GIP) Retatrutide RCS Research Peptides |
Description
Sandoz CEO says $40$50 monthly pricing could triple patient access to weight-loss drugs
The SUMMIT trial delivered positive results and glowing headlines but gosh its design was curiously weak.
Tirzepatide and Semaglutide are both powerful weight loss medications, but what sets them apart
During perimenopause, hormonal changes can lead to weight gain, belly fat, cravings, and slow metabolism
Sports athletes appreciate being able to take these on the go
Aims/hypothesis Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two peptides that function to promote insulin secretion
